SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
09-Aug-24 5:24 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 08-Aug-24 | Payment of Exercise | 1,466 | $12.73 | $18,662.20 | (7%) 20.25K to 18.78K | |
15-Jul-24 5:29 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Jul-24 | Option Exercise | 5,375 | $8.99 | $48,321.20 | 25% 21.72K to 27.09K | |
15-Jul-24 5:29 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Jul-24 | Planned Option Sale | 3,104 | $17.08 | $53,016.30 | (11%) 27.09K to 23.99K | |
15-Jul-24 5:29 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Jul-24 | Sale (Planned) | 2,271 | $17.08 | $38,788.70 | (9%) 23.99K to 21.72K | |
15-Jul-24 5:29 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Jul-24 | Planned Option Sale | 2,271 | $15.04 | $34,155.80 | (9%) 23.99K to 21.72K | |
15-Jul-24 5:29 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Jul-24 | Sale (Planned) | 4,299 | $15.07 | $64,785.90 | (15%) 28.29K to 23.99K | |
14-Feb-24 8:15 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Grant | 2,576 | -- | -- | 10% 26.47K to 29.04K | |
14-Feb-24 8:15 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Payment of Exercise | 755 | $12.41 | $9,369.55 | (3%) 29.04K to 28.29K | |
06-Dec-23 8:24 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Dec-23 | Sale | 534 | $9.63 | $5,142.42 | (2%) 27.0K to 26.47K | |
09-Aug-24 5:24 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 08-Aug-23 | Payment of Exercise | 1,467 | $17.23 | $25,276.40 | (5%) 27.0K to 25.53K | |
28-Nov-22 6:28 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 23-Nov-22 | Grant | 7,000 | -- | -- | 35% 20.0K to 27.0K | |
11-Aug-22 4:32 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 08-Aug-22 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K |